{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:08:37Z","timestamp":1790050117772,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":477,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico (CNPq)"},{"name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro (FAPERJ)"},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"},{"name":"Programas de Apoio a N\u00facleos de Excel\u00eancia (PRONEX)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ijantimicag.2011.11.008","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T18:39:42Z","timestamp":1326134382000},"page":"326-331","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB\/c mice"],"prefix":"10.1016","volume":"39","author":[{"given":"Joseane Lima Prado","family":"Godinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00edntia","family":"Simas-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosane","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tur\u00e1n Peter","family":"\u00dcrmenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderley","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliany Cola Fernandes","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4269\/ajtmh.1991.44.536","article-title":"Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease","volume":"44","author":"Barral","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0074-02761994000300027","article-title":"The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia","volume":"89","author":"Lainson","year":"1994","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/jnci\/64.6.1301","article-title":"Destruction of human solid tumors by alkyl lysophospholipids","volume":"64","author":"Runge","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0166-6851(87)90146-0","article-title":"Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes","volume":"23","author":"Achterberg","year":"1987","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0035","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/0006-2952(87)90543-0","article-title":"The activity of alkyl phosphorylcholines and related derivates against Leishmania donovani","volume":"36","author":"Croft","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0040","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/jac\/38.6.1041","article-title":"The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei","volume":"38","author":"Croft","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0050","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","article-title":"Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice","volume":"36","author":"Kuhlencord","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1590\/S0074-02762011000400015","article-title":"The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil","volume":"106","author":"Morais-Teixeira","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0060","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425255.4.9.1209","article-title":"Treatment of leishmaniasis with miltefosine: 2008 status","volume":"4","author":"Berman","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0065","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent","volume":"33","author":"Soto","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0070","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for New World cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/510588","article-title":"Treatment of Bolivian mucosal leishmaniasis with miltefosine","volume":"44","author":"Soto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4269\/ajtmh.2009.81.387","article-title":"Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia","volume":"81","author":"Soto","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.11.008_bib0090","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.trstmh.2006.02.022","article-title":"Treatment of New World cutaneous leishmaniasis with miltefosine","volume":"100","author":"Soto","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4269\/ajtmh.2010.10-0060","article-title":"Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis","volume":"83","author":"V\u00e9lez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial","volume":"4","author":"Machado","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus, Brazil","volume":"84","author":"Chrusciak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vetpar.2011.05.009","article-title":"Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil","volume":"181","author":"Andrade","year":"2011","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0115","first-page":"2","article-title":"Oral miltefosine may revolutionize treatment of visceral leishmaniasis. The potential impact of miltefosine on visceral leishmaniasis in India","volume":"68","author":"Ganguly","year":"2002","journal-title":"TDR News"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(03)00093-8","article-title":"Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR","volume":"129","author":"Cummings","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0130","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/AAC.00809-10","article-title":"Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis","volume":"54","author":"Aguiar","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0135","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/jac\/dkp365","article-title":"Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burden","volume":"64","author":"Aguiar","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0140","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1128\/AAC.00505-09","article-title":"Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis","volume":"53","author":"Serrano-Mart\u00edn","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/nar\/5.2.491","article-title":"Sequence arrangement of the 16S and 26S rRNA genes in the pathogenic haemoflagellate Leishmania donovani","volume":"2","author":"Leon","year":"1978","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2011.11.008_bib0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-4924-2-7","article-title":"Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression","volume":"2","author":"Conlon","year":"2003","journal-title":"J Biol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791100464X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791100464X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T04:02:55Z","timestamp":1561176175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791100464X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S092485791100464X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.11.008","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}